Why Early Tuesday’s Biotech Edge Is Bullish – Seekingalpha.com

It turns out Zogenix received good news: SAN DIEGO, July 16, 2012 (GLOBE NEWSWIRE): Zogenix, Inc. , a pharmaceutical company commercializing and developing products for the treatment … than you’re willing to lose, as biotech investing can be very risky.